Descriptive Outcome Based Study for Treatment Strategies of Lower Respiratory Tract Infections using Medication Therapy Management

Authors

  • N. Thanushree Vth Pharm. D, Gautham college of Pharmacy, Bengaluru, Karnataka-560032, India. Author
  • Gade. Kalyani Department of Pharmacology and Pharmacy Practice, Gautham College of Pharmacy, Bengaluru, Karnataka, India-560032. Author
  • Rinku Mathappan Department of Pharmacognosy, Gautham college of Pharmacy, Bengaluru-560032, Karnataka, India. Author

Keywords:

white blood cells, comorbid conditions, Clinical pharmacist, Anti-microbial therapy, Lower respiratory tract infections, Medication therapy management

Abstract

Lower respiratory tract infections (LRTI`s) are the fifth leading cause of death due to infections being responsible for 2.74 million deaths worldwide. Antibiotics are used primarily to treat these infections. The aim of this research is to study the medication therapy management of patients with lower respiratory tract infections admitted in ESI hospital, Bangalore, and to improve the quality of life of patients. It is a descriptive, observational, and interventional study. The data is collected through suitably designed forms and by direct interaction with the patients as well as their caretakers. The study cohort consists of 40 patients, of that males were 24 (60%) and females were 16 (40%). Most of the infected cases were in the age group of 51 to 60 years and the minimum infected were of 11 to 20 years and 81 to 90 years. The symptoms like Hyperthermia (30%), Tachycardia, and tachypnea (32.5%) were observed. A high count of RBS, PPBS, FBS were seen among 25%. Observations including leukocytopenia (7.5%), neutropenia (15%), lymphocytopenia (22.5%), leukocytosis (22.5%), neutrophilia (27.5%), lymphocytosis (35%), eosinophilia (7.5%), monocytosis (2.5%), and all cases have increased ESR (100%). LRTI was among 13 (32.5%) patients and remaining were with complications associated with LRTI. 40 (100%) patients received IV fluids along with Duolin, Budecort, Augmentin, Cough syrup, and Deriphylline. Maximum drug interactions are seen in Pantoprazole + Deriphylline combination among 14 (35%). Process measures (type and frequency of drug therapy problems detected), economic measures (number of medications dispensed), and humanistic measures, (patient satisfaction with services) were the main outcomes in this process after providing MTM services.

Downloads

Download data is not yet available.
Haematology reports in LRTI hospitalized

Downloads

Published

25-06-2020

Issue

Section

Research Article

How to Cite

Descriptive Outcome Based Study for Treatment Strategies of Lower Respiratory Tract Infections using Medication Therapy Management. (2020). International Journal of Research in Clinical and Hospital Pharmacy, 2(2), 33-42. https://rubatosis.org/journals/index.php/ijrhcp/article/view/168

Similar Articles

1-10 of 33

You may also start an advanced similarity search for this article.